Medpace Holdings, Inc. Earnings Per Share (Diluted)
Medpace Holdings, Inc. (MEDP) reported Earnings Per Share (Diluted) of $4.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-23
- Medpace Holdings, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was $4.25, a 37.10% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $4.28, a 16.62% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $4.66, a 27.03% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $3.86, a 28.24% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, diluted for fiscal 2025 was $15.28, a 20.98% increase from fiscal 2024.
- Medpace Holdings, Inc. earnings per share, diluted for fiscal 2024 was $12.63, a 42.23% increase from fiscal 2023.
- Medpace Holdings, Inc. earnings per share, diluted for fiscal 2023 was $8.88, a 21.98% increase from fiscal 2022.
- Medpace Holdings, Inc. earnings per share, diluted for fiscal 2022 was $7.28, a 51.35% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.25 10-Q · filed 2026-07-23 | $8.53 10-Q · filed 2026-07-23 | $13.19 derived: net income ÷ weighted average shares · filed 2026-07-23 | $17.05 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2026-03-31 | $4.28 10-Q · filed 2026-04-23 | $8.94 derived: net income ÷ weighted average shares · filed 2026-07-23 | $12.80 derived: net income ÷ weighted average shares · filed 2026-07-23 | $15.89 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2025-12-31 | $4.66 derived: net income ÷ weighted average shares · filed 2026-02-10 | $8.52 derived: net income ÷ weighted average shares · filed 2026-02-10 | $11.61 derived: net income ÷ weighted average shares · filed 2026-07-23 | $15.28 10-K · filed 2026-02-10 |
| 2025-09-30 | $3.86 10-Q · filed 2025-10-23 | $6.95 derived: net income ÷ weighted average shares · filed 2026-07-23 | $10.64 10-Q · filed 2025-10-23 | $14.31 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2025-06-30 | $3.10 10-Q · filed 2026-07-23 | $6.79 10-Q · filed 2026-07-23 | $10.47 derived: net income ÷ weighted average shares · filed 2026-07-23 | $13.46 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2025-03-31 | $3.67 10-Q · filed 2026-04-23 | $7.34 derived: net income ÷ weighted average shares · filed 2026-07-23 | $10.34 derived: net income ÷ weighted average shares · filed 2026-07-23 | $13.09 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2024-12-31 | $3.67 derived: net income ÷ weighted average shares · filed 2026-02-10 | $6.67 derived: net income ÷ weighted average shares · filed 2026-02-10 | $9.43 derived: net income ÷ weighted average shares · filed 2026-02-10 | $12.63 10-K · filed 2026-02-10 |
| 2024-09-30 | $3.01 10-Q · filed 2025-10-23 | $5.76 derived: net income ÷ weighted average shares · filed 2025-10-23 | $8.96 10-Q · filed 2025-10-23 | $11.43 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2024-06-30 | $2.75 10-Q · filed 2025-07-22 | $5.96 10-Q · filed 2025-07-22 | $8.42 derived: net income ÷ weighted average shares · filed 2026-02-10 | $10.64 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2024-03-31 | $3.20 10-Q · filed 2025-04-22 | $5.67 derived: net income ÷ weighted average shares · filed 2026-02-10 | $7.89 derived: net income ÷ weighted average shares · filed 2026-02-10 | $9.83 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2023-12-31 | $2.46 derived: net income ÷ weighted average shares · filed 2026-02-10 | $4.68 derived: net income ÷ weighted average shares · filed 2026-02-10 | $6.62 derived: net income ÷ weighted average shares · filed 2026-02-10 | $8.88 10-K · filed 2026-02-10 |
| 2023-09-30 | $2.22 10-Q · filed 2024-10-22 | $4.16 derived: net income ÷ weighted average shares · filed 2024-10-22 | $6.42 10-Q · filed 2024-10-22 | $8.54 derived: net income ÷ weighted average shares · filed 2025-02-11 |
| 2023-06-30 | $1.93 10-Q · filed 2024-07-23 | $4.20 10-Q · filed 2024-07-23 | $6.32 derived: net income ÷ weighted average shares · filed 2025-02-11 | $8.37 derived: net income ÷ weighted average shares · filed 2025-02-11 |
| 2023-03-31 | $2.27 10-Q · filed 2024-04-23 | $4.39 derived: net income ÷ weighted average shares · filed 2025-02-11 | $6.43 derived: net income ÷ weighted average shares · filed 2025-02-11 | $7.88 derived: net income ÷ weighted average shares · filed 2025-02-11 |
| 2022-12-31 | $2.12 derived: net income ÷ weighted average shares · filed 2025-02-11 | $4.17 derived: net income ÷ weighted average shares · filed 2025-02-11 | $5.62 derived: net income ÷ weighted average shares · filed 2025-02-11 | $7.28 10-K · filed 2025-02-11 |
| 2022-09-30 | $2.05 10-Q · filed 2023-10-24 | $3.50 derived: net income ÷ weighted average shares · filed 2023-10-24 | $5.18 10-Q · filed 2023-10-24 | $6.47 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2022-06-30 | $1.46 10-Q · filed 2023-07-25 | $3.16 10-Q · filed 2023-07-25 | $4.47 derived: net income ÷ weighted average shares · filed 2024-02-13 | $5.76 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2022-03-31 | $1.69 10-Q · filed 2023-04-25 | $3.00 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.29 derived: net income ÷ weighted average shares · filed 2024-02-13 | $5.35 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2021-12-31 | $1.32 derived: net income ÷ weighted average shares · filed 2024-02-13 | $2.62 derived: net income ÷ weighted average shares · filed 2024-02-13 | $3.67 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.81 10-K · filed 2024-02-13 |
| 2021-09-30 | $1.29 10-Q · filed 2022-10-25 | $2.35 derived: net income ÷ weighted average shares · filed 2022-10-25 | $3.49 10-Q · filed 2022-10-25 | $4.85 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-06-30 | $1.06 10-Q · filed 2022-07-26 | $2.20 10-Q · filed 2022-07-26 | $3.56 derived: net income ÷ weighted average shares · filed 2023-02-14 | $4.65 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-03-31 | $1.14 10-Q · filed 2022-04-26 | $2.50 derived: net income ÷ weighted average shares · filed 2023-02-14 | $3.59 derived: net income ÷ weighted average shares · filed 2023-02-14 | $4.24 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2020-12-31 | $1.35 derived: net income ÷ weighted average shares · filed 2023-02-14 | $2.45 derived: net income ÷ weighted average shares · filed 2023-02-14 | $3.10 derived: net income ÷ weighted average shares · filed 2023-02-14 | $3.84 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.09 10-Q · filed 2021-10-26 | $1.75 derived: net income ÷ weighted average shares · filed 2021-10-26 | $2.50 10-Q · filed 2021-10-26 | $3.30 derived: net income ÷ weighted average shares · filed 2022-02-15 |
| 2020-06-30 | $0.64 10-Q · filed 2021-07-27 | $1.40 10-Q · filed 2021-07-27 | $2.20 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.83 derived: net income ÷ weighted average shares · filed 2022-02-15 |
| 2020-03-31 | $0.76 10-Q · filed 2021-04-27 | $1.55 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.18 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.92 derived: net income ÷ weighted average shares · filed 2022-02-15 |
| 2019-12-31 | $0.78 10-K · filed 2020-02-25 | $1.42 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.16 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.67 10-K · filed 2022-02-15 |
| 2019-09-30 | $0.63 10-Q · filed 2020-10-27 | $1.37 derived: net income ÷ weighted average shares · filed 2020-10-27 | $1.88 10-Q · filed 2020-10-27 | $2.49 derived: net income ÷ weighted average shares · filed 2021-02-16 |
| 2019-06-30 | $0.73 10-Q · filed 2020-07-28 | $1.24 10-Q · filed 2020-07-28 | $1.86 derived: net income ÷ weighted average shares · filed 2021-02-16 | $2.38 derived: net income ÷ weighted average shares · filed 2021-02-16 |
| 2019-03-31 | $0.51 10-Q · filed 2020-04-29 | $1.13 derived: net income ÷ weighted average shares · filed 2021-02-16 | $1.65 derived: net income ÷ weighted average shares · filed 2021-02-16 | $2.10 derived: net income ÷ weighted average shares · filed 2021-02-16 |
| 2018-12-31 | $0.61 10-K · filed 2020-02-25 | $1.13 derived: net income ÷ weighted average shares · filed 2021-02-16 | $1.58 derived: net income ÷ weighted average shares · filed 2021-02-16 | $1.97 10-K · filed 2021-02-16 |
| 2018-09-30 | $0.52 10-K · filed 2020-02-25 | $0.97 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.36 10-Q · filed 2019-10-29 | $1.67 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-06-30 | $0.45 10-K · filed 2020-02-25 | $0.85 10-Q · filed 2019-07-30 | $1.15 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.39 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-03-31 | $0.40 10-K · filed 2020-02-25 | $0.70 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.94 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.17 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2017-12-31 | $0.30 10-K · filed 2019-02-26 | $0.55 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.78 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.98 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.25 10-K · filed 2019-02-26 | $0.48 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.69 10-Q · filed 2018-10-30 | $0.68 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2017-06-30 | $0.23 10-K · filed 2019-02-26 | $0.44 10-Q · filed 2018-07-31 | $0.43 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.57 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2017-03-31 | $0.20 10-K · filed 2019-02-26 | $0.20 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.33 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.48 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | $0.13 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.27 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.37 10-K · filed 2019-02-26 |
| 2016-09-30 | $0.13 10-K · filed 2018-02-27 | $0.28 derived: net income ÷ weighted average shares · filed 2018-02-27 | $0.39 10-Q · filed 2017-10-31 | $0.14 derived: net income ÷ weighted average shares · filed 2018-02-27 |
| 2016-06-30 | $0.15 10-K · filed 2018-02-27 | $0.26 10-Q · filed 2017-08-01 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-02-27 |
| 2016-03-31 | $0.11 10-K · filed 2018-02-27 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-02-27 | |
| 2015-12-31 | -$0.27 10-K · filed 2017-02-28 | -$0.28 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.28 10-K · filed 2018-02-27 | |
| 2015-09-30 | $0.00 10-K · filed 2017-02-28 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-03-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2014-12-31 | -$0.46 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |